Significant differences among physician specialties in management recommendations of BRCA1 mutation carriers

被引:25
作者
Dhar, S. U.
Cooper, H. P. [2 ]
Wang, T. [3 ]
Parks, B. [1 ]
Staggs, S. A. [4 ]
Hilsenbeck, S. [2 ,3 ]
Plon, S. E. [1 ,3 ,5 ]
机构
[1] Baylor Coll Med, Dept Mol & Human Genet, Feigin Ctr, Houston, TX 77030 USA
[2] Baylor Coll Med, Dept Med, Houston, TX 77030 USA
[3] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA
[4] Texas Med Assoc, Phys Oncol Educ Program, Austin, TX USA
[5] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA
关键词
BRCA1; BRCA; Surveillance; Guidelines; Physicians; BREAST-CANCER; PROPHYLACTIC MASTECTOMY; HEREDITARY BREAST/OVARIAN; MAMMOGRAPHY; KNOWLEDGE; GENETICS; RISK; MRI; GUIDELINES; WOMEN;
D O I
10.1007/s10549-011-1449-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The National Comprehensive Cancer Network (NCCN) has published guidelines for hereditary breast and ovarian cancer syndrome (HBOCS) management. Little data exist on compliance with these guidelines among different physician specialties. We performed an on-line case-based survey by randomly sampling physicians from five specialties, Family Medicine (FM), Obstetrics and Gynecology (OG), General Surgery (GS), Internal Medicine (IM), and Hematology and Oncology (HO). The physicians (n = 225) were asked to provide HBOCS management of healthy women ages 40-42 in the presence of a familial BRCA1 mutation. For women negative for the BRCA1 mutation, 59% of the physicians recommended appropriate surveillance although with significant differences among specialties; P = 0.01. Using an aggregate screening intensity score, physicians clearly recommended more intense screening for mutation positive than negative women (P < 0.0001), but only 16% of physicians followed NCCN guidelines for BRCA1-positive women. Seventy-six percent of all physicians recommended breast MRI with significant variation among specialties ranging from 62% of FM to 89% of OG (P = 0.0020). Similarly, 63% of physicians recommended prophylactic oophorectomy, with 76 and 78% of GS and OG compared to 38% of IM (P < 0.0001) and 57% recommended prophylactic mastectomy ranging from 84% of HO to 32% of FM (P < 0.0001). Independent of specialty, respondents with BRCA testing experience recommended more intense management than those without; P = 0.021. Management recommendations of BRCA1 mutation carriers are not consistent with NCCN guidelines and vary by medical specialty and genetic testing experience. Targeted education of physicians by specialty is needed, so that optimal management is offered to these high-risk women.
引用
收藏
页码:221 / 227
页数:7
相关论文
共 26 条
[11]   Physicians' attitudes towards mammography and prophylactic surgery for hereditary breast/ovarian cancer risk and subsequently published guidelines [J].
Julian-Reynier, C ;
Eisinger, F ;
Moatti, JP ;
Sobol, H .
EUROPEAN JOURNAL OF HUMAN GENETICS, 2000, 8 (03) :204-208
[12]   Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition [J].
Kriege, M ;
Brekelmans, CTM ;
Boetes, C ;
Besnard, PE ;
Zonderland, HM ;
Obdeijn, IM ;
Manoliu, RA ;
Kok, T ;
Peterse, H ;
Tilanus-Linthorst, MMA ;
Muller, SH ;
Meijer, S ;
Oosterwijk, JC ;
Beex, LVAM ;
Tollenaar, RAEM ;
de Koning, HJ ;
Rutgers, EJT ;
Klijn, JGM .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (05) :427-437
[13]  
Loescher Lois J, 2009, Oncol Nurs Forum, V36, pE57, DOI 10.1188/09.ONF. E57-E67
[14]   Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation:: The hereditary breast cancer clinical study group [J].
Metcalfe, Kelly A. ;
Lubinski, Jan ;
Ghadirian, Parviz ;
Lynch, Henry ;
Kim-Sing, Charmaine ;
Friedman, Eitan ;
Foulkes, William D. ;
Domchek, Susan ;
Ainsworth, Peter ;
Isaacs, Claudine ;
Tung, Nadine ;
Gronwald, Jacek ;
Cummings, Shelly ;
Wagner, Teresa ;
Manoukian, Siranoush ;
Moller, Pal ;
Weitzel, Jeffrey ;
Sun, Ping ;
Narod, Steven A. .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (07) :1093-1097
[15]  
O'Malley M S, 1997, N C Med J, V58, P176
[16]   The utility of MRI for the screening and staging of breast cancer [J].
Patani, N. ;
Mokbel, K. .
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2008, 62 (03) :450-453
[17]   Genetic testing and cancer risk management recommendations by physicians for at-risk relatives [J].
Plon, Sharon E. ;
Cooper, H. Paul ;
Parks, Bethany ;
Dhar, Shweta U. ;
Kelly, P. Adam ;
Weinberg, Armin D. ;
Staggs, Stephanie ;
Wang, Tao ;
Hilsenbeck, Susan .
GENETICS IN MEDICINE, 2011, 13 (02) :148-154
[18]  
Polednak A P, 1998, Conn Med, V62, P3
[19]   Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations [J].
Rebbeck, TR ;
Lynch, HT ;
Neuhausen, SL ;
Narod, SA ;
van't Veer, L ;
Garber, JE ;
Evans, G ;
Isaacs, C ;
Daly, MB ;
Matloff, E ;
Olopade, OI ;
Weber, BL .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (21) :1616-1622
[20]   Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers:: The PROSE study group [J].
Rebbeck, TR ;
Friebel, T ;
Lynch, HT ;
Neuhausen, SL ;
van't Veer, L ;
Garber, JE ;
Evans, GR ;
Narod, SA ;
Isaacs, C ;
Matloff, E ;
Daly, MB ;
Olopade, OI ;
Weber, BL .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (06) :1055-1062